In melanoma, knockdown of FTO promotes YTHDF2-mediated PD-1, CXCR4, and SOX10 mRNA decay, sensitizing melanoma cells to interferon-gamma and anti-PD-1 therapy [135]. This evidence concerns the gene YTHDF2 and melanoma.